Skip to main content

Day: May 8, 2023

Discovery Reports Q1 2023 Financial Results and Update

TORONTO, May 08, 2023 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) is pleased to announce its financial results for the first quarter (“Q1 2023”) ended March 31, 2023, and to provide a summary of key events for the quarter and subsequent to quarter-end. All figures are stated in Canadian dollars (“C$”) unless otherwise noted. Discovery’s flagship project is the 100%-owned Cordero silver project (“Cordero” or the “Project”) located in Chihuahua State, Mexico. HIGHLIGHTS FROM Q1 2023 & SUBSEQUENT EVENTS:Completion of our PFS on Cordero that outlined an 18-year mine life with average annual production of 33 Moz AgEq at an average AISC of $12.80/oz AgEq in Years 1 to 12. The after-tax NPV5% was US$1.2 B and the IRR was 28% at base case metal prices of Ag – US$22.00/oz,...

Continue reading

Diana Shipping Inc. Announces Time Charter Contracts for m/v Santa Barbara With Smart Gain and m/v Phaidra With Aquavita

ATHENS, Greece, May 08, 2023 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Smart Gain Shipping Co., Limited, for one of its Capesize dry bulk vessels, the m/v Santa Barbara. The gross charter rate is US$21,250 per day, minus a 5% commission paid to third parties, for a period until minimum October 10, 2024 up to maximum December 10, 2024. The charter commenced on May 7, 2023. The “Santa Barbara” is a 179,426 dwt Capesize dry bulk vessel built in 2015. The Company also announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Aquavita International...

Continue reading

Blockmate Ventures to launch solar token with Sunified Group

VANCOUVER, British Columbia and AMSTERDAM, May 08, 2023 (GLOBE NEWSWIRE) — Blockmate Ventures Inc (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH1) (“Blockmate” or the “Company”) and Sunified Group B.V. KVK# 82922713 (“Sunified”) are pleased to announce that they have agreed to work together to launch the world’s first solar energy oracle token. This global service will leverage Sunified’s patented UNITY sensor hardware and trust anchoring to digitize electrons directly on solar panels. Sunified is creating & partnering to build solar projects across Europe and Australia as part of a unique strategy that develops Smart Solar Parks that are easier to build, closer to where energy is needed, and benefit from short construction times, moving forward DeFi and Web3 infrastructure for project capital formation and...

Continue reading

New Data by Academic Researchers Highlights Biological Activity of Simufilam on Filamin A

New in vitro data from Europe show that simufilam can reverse altered filamin A protein (FLNA) in pituitary tumor cells, leading to improved cell signaling. Data suggest FLNA is a central factor influencing pituitary tumor cell behavior. Data to be presented at the European Society of Endocrinology, May 13-16th.AUSTIN, Texas, May 08, 2023 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company, today announced new data from European researchers that highlight the bioactivity of simufilam on the filamin A (FLNA) protein. Prior research has shown that FLNA is altered in pituitary tumor cells, leading to impaired cell signaling. New in vitro data now show that simufilam can reverse this FLNA alteration in pituitary tumor cells, leading to improved cell signaling. The data also suggest that...

Continue reading

Mountain Valley MD Executes Soluvec™ 1% License Agreement, Expands Patent Protection

TORONTO, May 08, 2023 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (OTCQB: MVMDF) (FRA: 20MP) is pleased to announce that Mountain Valley MD Inc. (“Mountain Valley”) has entered into a license agreement (the “Agreement”) with a privately held Ontario corporation (the “Licensee”) for its Soluvec™1% animal husbandry applications for the territory of the People’s Republic of Bangladesh. As previously disclosed, the Company has applied its Quicksol™ solubilization technology to the drug Ivermectin to create its Soluvec™ 1% product formulation, which was designed to provide a safer and more effective solution that can be administered broadly across the husbandry animal and aquatic species marketplace. Mountain Valley has worked closely with the Licensee and its...

Continue reading

Decisions of the Annual General Meeting of UAB “Atsinaujinančios Energetikos Investicijos” Shareholders

The general ordinary meeting of shareholders of the UAB “Atsinaujinančios Energetikos Investicijos” (the Company) was held on 20 April 2023. The following decisions were made:THE AGENDA QUESTION: Approval of the audited financial statements of the Company and Group for the year 2022THE DECISION: The set of financial statements of the Company and Group for 2022 has been approvedTHE AGENDA QUESTION: Approval of the Company’s profit/loss allocation for the year 2022THE DECISION: The distribution of profit (loss) of Company for the year 2022 has been approved:Article Thousand, EURRetained earnings (loss) – at the beginning of financial year 14,036Comprehensive income for the reporting period – net profit for the current year 13,360Profit transfer to the legal reserve -283Retained earnings (loss) – at the...

Continue reading

Imperial Petroleum Inc. Reports Record Net Income of $35.7 Million for the First Quarter of 2023 Financial and Operating Results

ATHENS, Greece, May 08, 2023 (GLOBE NEWSWIRE) — IMPERIAL PETROLEUM INC. (NASDAQ: IMPP, the “Company”), a ship-owning company providing petroleum products, crude oil and dry bulk seaborne transportation services, announced today its unaudited financial and operating results for the first quarter ended March 31, 2023. OPERATIONAL AND FINANCIAL HIGHLIGHTSFleet operational utilization of 85% in Q1 23’ with 6 days of technical off hire and 495 (54%) of our fleet days dedicated to spot activity. Delivery of 2 Handysize dry bulk carriers, the Glorieuse and the Eco Wildfire, towards the end of March 2023 – expanding our fleet to 12 vessels. Revenues of $65.4 million in Q1 23’ – up $60.3 million or 1,182% from Q1 22’. Record net income of $35.7 million in Q1 23’ up by $35.5 million compared to Q1 22’ or 17,750%. EBITDA1 of...

Continue reading

Go1 acquires Blinkist, launching a new model of learning

BRISBANE, Australia, May 08, 2023 (GLOBE NEWSWIRE) — Go1, the world’s learning content expert, announced today the acquisition of Blinkist, a mobile-first learning app that summarizes key ideas from professional books and podcasts which is used by tens of millions of people worldwide. The acquisition forms the foundation of an innovative new model of corporate learning which seeks to engage learners throughout their day-to-day lives. Go1 has made a name for itself as an aggregator of learning and development content, offering access to tens of thousands of short-form courses that are typically consumed in a corporate setting. However, engaging learners on a grand scale relies not only on democratizing access to more types of learning content but also on making that content available in more places, meeting learners where they...

Continue reading

Prelude Therapeutics Announces First Quarter 2023 Financial Results and Operations Update

Eight abstracts presented at AACR 2023 demonstrate progress of the pipeline Cash runway unchanged, supporting operations into the fourth quarter of 2024 WILMINGTON, Del., May 08, 2023 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today reported financial results for the first quarter ended March 31, 2023, and provided an update on recent clinical and development pipeline progress. “Our recent presentations at the 2023 AACR Annual Meeting highlight the meaningful progress we made across our clinical and preclinical pipeline programs. In addition to our clinical presentations on PRT2527 (CDK9 inhibitor) and PRT1419 (MCL-1 Inhibitor) that demonstrated differentiated and potential best-in-class PK/PD profiles of these molecules, our preclinical research demonstrated...

Continue reading

Galaxy Gaming® Launches Next-Generation Galaxy Operating System™

LAS VEGAS, May 08, 2023 (GLOBE NEWSWIRE) — Galaxy Gaming, Inc. (OTC: GLXZ), the world’s largest independent developer and distributor of casino table games and technology announced the launch of Galaxy Operating System (GOS), the next-generation game management system featuring innovative progressive jackpot options, striking LED sensors, and first-of-its kind digital tracking. “GOS pairs our extensive knowledge of table games progressives with a modern approach to table management systems resulting in this dynamic and scalable operating system,” said Todd Cravens, President and CEO of Galaxy Gaming. “We believe that this is greater than just a progressive system. It’s a full operating system designed to evolve with the industry, our partners, and chiefly, with what players want. We can’t wait to thrill players with the GOS experience.” Galaxy...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.